BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33780296)

  • 1. A Method for Determining the Kinetics of Small-Molecule-Induced Ubiquitination.
    Vieux EF; Agafonov RV; Emerson L; Isasa M; Deibler RW; Simard JR; Cocozziello D; Ladd B; Lee L; Li H; Archer S; Fitzgerald M; Michael R; Nasveschuk CG; Park ES; Kern G; Proia DA; Phillips AJ; Fisher SL
    SLAS Discov; 2021 Apr; 26(4):547-559. PubMed ID: 33780296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK Family PROTAC Profiling Reveals Distinct Kinetic Responses and Cell Cycle-Dependent Degradation of CDK2.
    Riching KM; Schwinn MK; Vasta JD; Robers MB; Machleidt T; Urh M; Daniels DL
    SLAS Discov; 2021 Apr; 26(4):560-569. PubMed ID: 33190579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Resistance Mechanisms to Targeted Protein Degradation Converge Toward Impairment of the Engaged Ubiquitin Transfer Pathway.
    Ottis P; Palladino C; Thienger P; Britschgi A; Heichinger C; Berrera M; Julien-Laferriere A; Roudnicky F; Kam-Thong T; Bischoff JR; Martoglio B; Pettazzoni P
    ACS Chem Biol; 2019 Oct; 14(10):2215-2223. PubMed ID: 31553577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
    Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
    Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cereblon-dependent targeted protein degrader by visualizing the spatiotemporal ternary complex formation in cells.
    Kaji T; Koga H; Kuroha M; Akimoto T; Hayata K
    Sci Rep; 2020 Feb; 10(1):3088. PubMed ID: 32080280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bardoxolone conjugation enables targeted protein degradation of BRD4.
    Tong B; Luo M; Xie Y; Spradlin JN; Tallarico JA; McKenna JM; Schirle M; Maimone TJ; Nomura DK
    Sci Rep; 2020 Sep; 10(1):15543. PubMed ID: 32968148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.
    Collins I; Wang H; Caldwell JJ; Chopra R
    Biochem J; 2017 Mar; 474(7):1127-1147. PubMed ID: 28298557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted protein degradation via intramolecular bivalent glues.
    Hsia O; Hinterndorfer M; Cowan AD; Iso K; Ishida T; Sundaramoorthy R; Nakasone MA; Imrichova H; Schätz C; Rukavina A; Husnjak K; Wegner M; Correa-Sáez A; Craigon C; Casement R; Maniaci C; Testa A; Kaulich M; Dikic I; Winter GE; Ciulli A
    Nature; 2024 Mar; 627(8002):204-211. PubMed ID: 38383787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.).
    Gandhi AK; Kang J; Havens CG; Conklin T; Ning Y; Wu L; Ito T; Ando H; Waldman MF; Thakurta A; Klippel A; Handa H; Daniel TO; Schafer PH; Chopra R
    Br J Haematol; 2014 Mar; 164(6):811-21. PubMed ID: 24328678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitination and degradation of c-Jun.
    Yang J; Huang M; Zhou L; He X; Jiang X; Zhang Y; Xu G
    J Biol Chem; 2018 Jun; 293(26):10141-10157. PubMed ID: 29748389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkenyl oxindole is a novel PROTAC moiety that recruits the CRL4DCAF11 E3 ubiquitin ligase complex for targeted protein degradation.
    Wang Y; Wei T; Zhao M; Huang A; Sun F; Chen L; Lin R; Xie Y; Zhang M; Xu S; Sun Z; Hong L; Wang R; Tian R; Li G
    PLoS Biol; 2024 May; 22(5):e3002550. PubMed ID: 38768083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.
    Akuffo AA; Alontaga AY; Metcalf R; Beatty MS; Becker A; McDaniel JM; Hesterberg RS; Goodheart WE; Gunawan S; Ayaz M; Yang Y; Karim MR; Orobello ME; Daniel K; Guida W; Yoder JA; Rajadhyaksha AM; Schönbrunn E; Lawrence HR; Lawrence NJ; Epling-Burnette PK
    J Biol Chem; 2018 Apr; 293(16):6187-6200. PubMed ID: 29449372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.
    Ward CC; Kleinman JI; Brittain SM; Lee PS; Chung CYS; Kim K; Petri Y; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Nomura DK
    ACS Chem Biol; 2019 Nov; 14(11):2430-2440. PubMed ID: 31059647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cereblon-mediated degradation of the amyloid precursor protein via the ubiquitin-proteasome pathway.
    Kurihara T; Asahi T; Sawamura N
    Biochem Biophys Res Commun; 2020 Mar; 524(1):236-241. PubMed ID: 31983437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mental retardation-linked nonsense mutation in cereblon is rescued by proteasome inhibition.
    Xu G; Jiang X; Jaffrey SR
    J Biol Chem; 2013 Oct; 288(41):29573-85. PubMed ID: 23983124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains.
    Kaiho-Soma A; Akizuki Y; Igarashi K; Endo A; Shoda T; Kawase Y; Demizu Y; Naito M; Saeki Y; Tanaka K; Ohtake F
    Mol Cell; 2021 Apr; 81(7):1411-1424.e7. PubMed ID: 33567268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency.
    Chaudhry C
    J Med Chem; 2023 May; 66(9):6239-6250. PubMed ID: 37102218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CKIP-1 couples Smurf1 ubiquitin ligase with Rpt6 subunit of proteasome to promote substrate degradation.
    Wang Y; Nie J; Wang Y; Zhang L; Lu K; Xing G; Xie P; He F; Zhang L
    EMBO Rep; 2012 Nov; 13(11):1004-11. PubMed ID: 23032291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Proteolysis-Targeting Chimera Molecules that Selectively Degrade the IRAK3 Pseudokinase.
    Degorce SL; Tavana O; Banks E; Crafter C; Gingipalli L; Kouvchinov D; Mao Y; Pachl F; Solanki A; Valge-Archer V; Yang B; Edmondson SD
    J Med Chem; 2020 Sep; 63(18):10460-10473. PubMed ID: 32803978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology.
    Ito T; Yamaguchi Y; Handa H
    Cell Chem Biol; 2021 Jul; 28(7):987-999. PubMed ID: 34033753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.